SRDX
Price:
$38.83
Market Cap:
$553.99M
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other market...[Read more]
Industry
Medical - Devices
IPO Date
1998-03-04
Stock Exchange
NASDAQ
Ticker
SRDX
According to Surmodics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -431.44. This represents a change of -838.14% compared to the average of 58.45 of the last 4 quarters.
The mean historical PE Ratio of Surmodics, Inc. over the last ten years is 39.11. The current -431.44 PE Ratio has changed -110401.71% with respect to the historical average. Over the past ten years (40 quarters), SRDX's PE Ratio was at its highest in in the December 2019 quarter at 942.60. The PE Ratio was at its lowest in in the September 2021 quarter at -665.66.
Average
39.11
Median
30.17
Minimum
-293.13
Maximum
469.55
Discovering the peaks and valleys of Surmodics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.79%
Maximum Annual PE Ratio = 469.55
Minimum Annual Increase = -307.81%
Minimum Annual PE Ratio = -293.13
Year | PE Ratio | Change |
---|---|---|
2023 | -293.13 | 1.79% |
2022 | -15.51 | -108.59% |
2021 | 180.63 | -61.53% |
2020 | 469.55 | 482.10% |
2019 | 80.67 | -137.38% |
2018 | -215.82 | -307.81% |
2017 | 103.86 | 165.15% |
2016 | 39.17 | 85.10% |
2015 | 21.16 | 2.84% |
2014 | 20.58 | -9.27% |
The current PE Ratio of Surmodics, Inc. (SRDX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-42.67
5-year avg
84.44
10-year avg
39.11
Surmodics, Inc.’s PE Ratio is less than ProSomnus, Inc. Common Stock (-0.59), less than LivaNova PLC (-154.03), less than Electromed, Inc. (28.81), less than OrthoPediatrics Corp. (-28.25), less than NeuroPace, Inc. (-6.95), less than Inogen, Inc. (-2.89), less than Pulmonx Corporation (-4.92), less than Apyx Medical Corporation (-1.59), less than NuVasive, Inc. (68.48), less than CONMED Corporation (23.18), less than SI-BONE, Inc. (-15.32), less than AxoGen, Inc. (-34.41), less than Anika Therapeutics, Inc. (-4.91), less than Orthofix Medical Inc. (-5.12), less than Paragon 28, Inc. (-10.66), less than Integer Holdings Corporation (41.14), less than Sight Sciences, Inc. (-6.06),
Company | PE Ratio | Market cap |
---|---|---|
-0.59 | $8.18M | |
-154.03 | $2.56B | |
28.81 | $149.02M | |
-28.25 | $742.41M | |
-6.95 | $210.22M | |
-2.89 | $268.02M | |
-4.92 | $286.21M | |
-1.59 | $45.04M | |
68.48 | $2.08B | |
23.18 | $2.29B | |
-15.32 | $631.67M | |
-34.41 | $570.66M | |
-4.91 | $363.41M | |
-5.12 | $619.96M | |
-10.66 | $609.86M | |
41.14 | $4.33B | |
-6.06 | $319.45M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surmodics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Surmodics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Surmodics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Surmodics, Inc. (SRDX)?
What is the highest PE Ratio for Surmodics, Inc. (SRDX)?
What is the 3-year average PE Ratio for Surmodics, Inc. (SRDX)?
What is the 5-year average PE Ratio for Surmodics, Inc. (SRDX)?
How does the current PE Ratio for Surmodics, Inc. (SRDX) compare to its historical average?